Regulation on medicinal products subject to pharmacy and free-selling medicinal products

Unofficial table of contents

AMVerkRV

Date of completion: 24.11.1988

Full quote:

" Regulation on orphaned and free-selling medicinal products of 24 November 1988 (BGBl. 2150), as last amended by Article 3 of the Regulation of 19 December 2014 (BGBl). 2371).

Status:

Last amended by Art. 3 V v. 19.12.2014 I 2371

For more details, please refer to the menu under Notes

Footnote

(+ + + Recast of the Regulation on the authorisation of medicinal products for transport outside pharmacies 2121-50-1-8 (see: AMVerkZulV) and the Regulation on the exclusion of medicinal products from the market outside pharmacies 2121-50-1-9 (see: AMVerkV) + + +)
(+ + + Text certificate: 12.11.1988 + + +)

First section
Release from the pharmacy obligation

Unofficial table of contents

§ 1

(1) The following medicinal products within the meaning of Article 2 (1) or (2) (1) of the Medicinal Products Act, intended to serve for the disposal or alleviation of diseases, suffering, bodily injury or pathological ailments, shall be used for transport purposes. outside of pharmacies:

1.

Substances and preparations of substances and medicinal products within the meaning of Article 2 (2) (1) of the Medicinal Products Act, referred to in Appendix 1a to this Regulation, on the basis of the detailed description of this Annex; substances and preparations of substances may only be mixed with one another or with other substances or preparations of substances, to the extent that this is expressly permitted in the installation.

2.

Distillates, other than dry distillates, of mixtures of plants, parts of plants, essential oils, camphor, menthol, balsames or resins, as ready-to-use medicinal products, unless they are obtained from prescription or those used in Appendix 1b to the Regulation referred to in Regulation (EC) No

3.

Plants and parts of plants in the form of dragees, capsules or tablets as ready-to-use medicinal products, with the addition of non-active substances or preparations of substances, if they are not more than four of the substances referred to in Annex 1c to this Regulation. Plants and parts of plants are produced and the diameter of the Drageekerns or the tablet is at least 3 millimetres.

(2) In addition, for transport outside pharmacies, soluble tea infusion powders are released as aqueous complete trains in the form of ready-to-use medicinal products, which are

1.

one of the plants or parts thereof referred to in Appendix 1d to this Regulation, or

2.

Mixtures of not more than seven of the plants or their parts referred to in Annexes 1d and 1e to this Regulation and exclusively for use as "cough tea", "breast tea", "cough and breast tea", "magientee", "bowel tea", "stomach" and bowel tea "," sedative tea "or" diuretic tea " shall be placed on the market.

The addition of substances or preparations of substances which are not active in medicinal products shall be permitted. The ethereal oils of the initial drugs lost in the production may be replaced by type and quantity. Unofficial table of contents

§ 2

(1) Medicinal products within the meaning of Section 2 (1) or (2) (1) of the Medicines Act are also released for use in the form of ready-to-use medicinal products for transport outside of pharmacies, if they are intended solely for the purpose of:

1.

in the case of cough or hoarseness, provided that they contain no substances or preparations other than those referred to in Annex 2a to this Regulation, and provided that they are used in pharmaceutical forms for the purpose of lutching shall be placed on the market,

2.

if they contain no other substances or preparations other than those referred to in Appendix 2b to this Regulation, to be used as a seductive agent,

3.

in the case of chicken eyes or cornea, provided that they contain no other substances or preparations other than those referred to in Annex 2c to this Regulation in respect of medicinal products.

(2) The medicinal products referred to in paragraph 1 may also be added to substances or preparations containing substances which are not active in the field of medicine. Unofficial table of contents

§ 3

§ § 1 and 2 shall not apply to medicinal products intended for injection or infusion, for rectal, vaginal or intrauterine use, for intramammary use in animals, as wound sticks, as implants and as aerosols up to a medium Particle size of not more than 5 mym for direct use on or in the body. Unofficial table of contents

§ 4

Medicinal products within the meaning of Article 2 (1) or (2) (1) of the Medicines Act are released for circulation outside the pharmacies.

1.

are intended solely for use in ornamental fish, ornamental or songbirds, pigeons, terrarids, small-naves, ferrets or non-food-producing rabbits; and

2.

shall not be subject to the obligation to presenter in accordance with Section 48 (1) of the Medicinal Products Act for the purposes of the respective application in the case of the species in question.

Unofficial table of contents

§ 5

The release of the medicinal products referred to in § § 1, 2 and 4 for transport outside pharmacies shall not be excluded by the fact that they are intended, in part, for purposes other than disposal or alleviation of diseases, Suffering, body damage or pathological ailments. Unofficial table of contents

§ 6

The release of the medicinal products referred to in § § 1, 2 and 4 for transport outside pharmacies shall be excluded, unless otherwise provided in this Regulation, if they are partially or exclusively intended for disposal or alleviation or relief. if they are intended in part for the prevention of the diseases or ailments referred to in Appendix 3.

Second section
Inclusion in the pharmacy requirement

Unofficial table of contents

§ 7

(1) The medicinal products referred to in § 44 (2) of the Medicines Act are excluded from the traffic outside the pharmacies if:

1.

they are the substances or preparations of substances referred to in Appendix 4 to this Regulation,

2.

the plants referred to in Appendix 1b to this Regulation, the parts thereof, preparations thereof or compacts,

3.

they are added to the substances or preparations of substances referred to in points 1 or 2,

4.

they are intended in part or exclusively for the elimination, alleviation or prevention of the diseases or ailments referred to in Appendix 3.

(2) The medicinal products referred to in § 44 (2) of the Medicinal Products Act, which are intended in part or exclusively for the elimination, alleviation or prevention of the diseases or ailments referred to in Appendix 3 (paragraph 1 (4)), are, however, for: the traffic outside of the pharmacies is released:

1.

Curative waters against the diseases and ailments listed in Appendix 3 of Section A (3) and (5) (d) and (e);

2.

Healers, bath-demos, other peloids and preparations for the production of baths, in so far as they are not placed on the market in small packages in the retail trade,

3.

the medicinal products referred to in Article 44 (2) (5) of the Medicinal Products Act.

Unofficial table of contents

§ 8

(1) The medicinal products referred to in § 44 (1) of the Medicines Act are excluded from the traffic outside the pharmacies if:

1.

they are the substances or preparations of substances referred to in Appendix 4 to this Regulation,

2.

the plants referred to in Appendix 1b to this Regulation, the parts thereof, preparations thereof or compacts,

3.

they are added to the substances or preparations of substances referred to in points 1 or 2,

4.

be partially or exclusively intended for the prevention of the diseases or ailments referred to in Appendix 3.

(2) Paragraph 1 (4) shall not apply to medicinal products intended for the prevention of diseases of ornamental fish, ornamental or sonic birds, pigeons, terrarium animals, small-nagers, ferrets or rabbits which are not used for the production of foodstuffs. Unofficial table of contents

§ 9

The medicinal products referred to in § 44 of the Medicines Act are also excluded from the market outside pharmacies if they are chemical compounds which, according to the findings of medical science, are
antibiotic,
blood clotting retarders,
Histamine adverse,
hormone-like,
parasympathicomimetical (cholinergic) or
parasympathicolytic,
sympathicomimetical (adrenergic) or sympathicolytic
Effect on the human or animal body. The same shall apply if such chemical compounds are added to them. Unofficial table of contents

§ 10

The medicinal products referred to in § 44 of the Medicines Act are also excluded from the market outside pharmacies if they are used for injection or infusion, for rectal or intrauterine use, for intramammary or vaginal use. animals, as implants or as aerosols up to a mean particle size of not more than 5 mym are placed on the market.

Third Section
Transitional and final provisions

Unofficial table of contents

§ 11

Medicinal products which are on the market on 31 January 2007 and which will be subject to the second Regulation amending the Regulation on pharmacies and medicinal products which are subject to pharmacies, may not be released until 1 May 2007 by continue to be placed on the market by pharmaceutical companies and thereafter by wholesalers and retailers. Unofficial table of contents

Annex 1a (to § 1 para. 1 no. 1)

(Fundstelle: BGBl. I 1988, 2153-2156;
with regard to of the individual amendments. Footnote)

Ethanol 
Ethanol-Aether-mixture in a ratio of 3: 1 (Hoffmannstropfen) 
Ethanol/water mixtures 
Aloe extract 
(a) for external use as an additive in finished medicinal products; 
(b) for internal use in a daily dose up to 20 mg 
 as a bitter agent in aqueous-alcoholic plant extracts 
 as ready-made medicinal product 
Aluminium acetate tartrate solution 
Aluminium acetate tartrate, 
 as tablets also with the addition of substances which are not active. 
 or preparations as ready-to-use products 
aluminium hydroxide, 
 also in mixtures with substances which are not active in medicinal products, or 
 Preparations as ready-to-use products 
Aluminium potassium sulphate (Alaun), 
 As bleeding pens or stones, also with the addition 
 Non-active substances or preparations 
Aluminium-magnesium-silicate-complexes, 
 as tablets, even with the addition of medicinal products not more effective 
 Substances or preparations as ready-to-use medicinal products 
Aluminium silicates, 
 as tablets, even with the addition of medicinal products not more effective 
 Substances or preparations as ready-to-use medicinal products 
Formic acid-ethanol-water mixture 
 (ant spiritus) with a content of total fumaric acid up to 
 1.25% with at least 70% ethanol 
Formic acid up to 65% ad us.  vet. 
-for the treatment of varroasis of bees, 
Ammonia solution up to 10% 
Ammonia-Lavender-Riechessenz 
Ammonium chloride 
Anisoil, essential (in your statement: "Atheran Anisoil") 
 also as a capsule, including with the addition of substances which are not active in medicine, or 
 Preparations, as ready-to-use medicinal products, each up to a maximum 
 Single dose of 0.1 g per capsule or  a maximum daily dose of 0.3 g 
Aniswater 
Arnika 
 and their preparations for external use, including 
 Addition of non-active substances or preparations 
Artichoke leaves and their preparations, 
 also with the addition of non-active substances or preparations, as ready-to-use medicinal products   
ascorbic acid (vitamin C), 
 also as tablets, even with the addition of medicinal products 
 more effective substances or preparations than 
 Medicinal products for manufacture 
Baldrian extract, 
 Also in mixtures with hops extract, melissa leaf extract 
 or passion flower extract, and with medicinal products not 
 effective substances or preparations, as ready-to-use medicinal products 
Baldrian tincture, 
 also ethereal, with ethanol-ether mixtures in the ratio 1: 5 
Baldria wine as a ready-to-use product 
Benedictine Essence as a ready-to-use medicine 
Benzo-tincture, with ethanol 90% in ratio 1: 5 
Birkenteer for outer use in animals 
boric acid and its salts for buffering and/or 
 Isotonization in wetting solutions or 
 Disinfection solutions for contact lenses 
Brausemagnesia 
calcium carbonate, 
 as tablets also with the addition of substances which are not active. 
 or preparations as ready-to-use products 
calcium citrate, calcium lactate, calcium phosphates, 
 also mixed, as tablets and mixtures 
 Also with the addition of ascorbic acid and medicinal product 
 Non-active substances or preparations as finished medicinal products 
Calcium hydroxide ad us.  vet. 
Calcium oxide ad us.  vet. 
Campherliniment, fleeting 
Camphor oil for external use 
Camphor ointment, 
 Also with the addition of essential oils, menthol and 
 Menglytate (ethyl glycollic acid menthyl ester) 
Camphor spiritus 
Chinawein, 
 also with iron, as ready-to-use medicinal product 
Citrus oil, ethereal 
Colloidal silver chloride solution, protein free, up to 0.5% 
 also with the addition of substances or preparations which are not active in medicinal products, 
 as a nasal disinfectant, as a ready-made drug 
Eibischsyrup as a ready-to-use medicine 
Enziantincture, from gentian root with ethanol 70% in the 
 Conversion ratio 1: 5 
2-(ethylmercurithio) benzoic acid, sodium salt 
 (Thiomersal) up to 30 mg with medicinal product 
 non-active substances or preparations as 
 Tablets for the control of the nosema 
 Bees as ready-to-use medicines 
Eucalyptus oil, ethereal 
(a) also as a capsule, including with the addition of non-active substances or preparations,   
 as ready-to-use medicinal product, each up to a maximum single dose of 0.2 g per capsule   
 and a maximum daily dose of 0.6 g 
(b) for external use, even with the addition of substances or preparations which are not active in medicinal products 
Eucalyptus water in a ratio of 1: 1 000 
Catching cowling and packing 
Feigensyrup, 
 also with Manna, as a ready-to-use product 
Fennel honey using at least one 
 50% honey, also with concentrated solutions of 
 Sweet-tasting mono-, disaccharides and glucose syrup, 
 as ready-to-use medicinal product, even with the addition of the non-active substance   
 Component phospholipids from soya beans (lecithin) 
Fennel oil, ethereal 
Fichtennadeloils, ätherische 
Fichtennadelspiritus with at least 70% ethanol 
Franzbranntwein, 
 Also with cooking salt, menthol, camphor, 
 Sprue needle and pine needle oil up to 0.5%, 
 Odours or colouring matter, with at least 45% ethanol 
Women's sheaths and preparations 
Fumagillin-1,1 '-bicyclohexyl-4-ylamine-salt 
 (Bicyclohexylammonium fumagillin) with medicinal product 
 non-active substances or preparations 
 Combating the health of bees as ready-to-use medicinal products 
Galgants ' roots and preparations 
Germerwurzelstock (Nieswurzel) in preparations with 
 a salary of up to 3% as snow-covered snuff 
Glycerol 85% (glycerol), 
 also with the addition of water 
Dentures for dentures 
Hard paraffin, 
 also with the addition of healers, swimwear or 
 other Peloids within the meaning of section 44 (2) (2) 
 of the Medicines Act or of medicinal products 
 non-active substances or preparations, 
 on external use 
Yeast, 
 as tablets also with the addition of substances which are not active. 
 or preparations as ready-to-use products 
Blueberry syrup as a ready-to-use product 
Heilerde for internal use, also in capsules 
Heublumenkompresses 
Holundersyrup as a ready-to-use medicine 
Wooden teas for external use in animals 
St John 's wort or St John' s wort 
 Extracts with oil as ready-to-use medicinal product 
Potassium carbonate 
Potassium citrate 
Potassium dihydrogen phosphate 
Potassium-(RR)-hydrogentartrate (Weinstein) 
Potassium natrium- (RR) tartrate 
Potassium sulphate 
Kalmusoil, ethereal 
Chamomile extracts, liquid, 
 Also with the addition of medicinal products 
 active substances or preparations, as ready-to-use medicinal products 
Chamomile extract, 
 Also with ointment base, as ready-to-use medicinal product 
Chamomile oil 
Camomile water 
Carmelite spirit as a ready-to-use medicine 
Pine needle oils, essential oils 
Garlic 
 and its preparations, even with the addition of medicinal products 
 -active substances or preparations 
Coal, medical, 
 as tablets or granules, even with the addition of medicinal products 
 Active substances or preparations as ready-to-use products 
Kondurangowein as a ready-to-use medicine 
Koriander oil, essential 
Krauseminzöl, ethereal 
Refrigerated ointment as ready-to-use product 
Cumin oil, ethereal, 
 Also in mixtures with other essential oils-except 
 Terpentine oil, with glycerol, linseed oil, liquid paraffin, 
 Finely divided sulphur or ethanol, for animals, as ready-to-use medicinal products 
Lactose (lactose) 
Lanolin 
Larch terpentin for external use in animals 
Lavender oil, essential 
Lavender spiritus 
Lavender Water 
Liver tran in capsules as ready-to-use medicines 
liver tranemulsion, 
 also flavoured, as ready-to-use medicinal product 
Lecithin, 
 also with the addition of non-active substances, or 
 Preparations as ready-to-use products 
Lincakes 
Linseed oil 
Linseed oil, sweaty, for external use 
Liniment, fleeting 
Lorbeeröl 
magnesium carbonate, basic, light and heavy, 
 as tablets, even with the addition of medicinal products not more effective 
 Substances or preparations as ready-to-use medicinal products 
magnesium hydrogen phosphate 
Magnesium oxide, light (magnesia, burnt) 
magnesium peroxide, up to 15%, 
 as tablets, even with the addition of medicinal products not more effective 
 Substances or preparations as ready-to-use medicinal products 
magnesium sulphate 7 H2O (bitter salt) 
magnesium trisilicate, 
 as tablets also with the addition of substances which are not active. 
 or preparations as ready-to-use products 
Almond oil 
Manna syrup as a ready-to-use medicine 
Melissa spirit as a ready-to-use medicine 
Melissa spiritus 
Melissa Water 
Mentholpins 
Methenamine silver nitrate (hexamethylenetetramine silver nitrate) 
 as Streupulver 2% with the addition of medicinally non-effective 
 Substances or preparations in weekly bed packs as 
 Medicinal products for manufacture 
Lactic acid up to 15% ad us.  vet. 
-for the treatment of varroasis of bees, 
Mint oil, ethereal, 
 Also with the addition of up to 5% ethanol 96% Ph.  Eur., as a ready-to-use product 
Mixtures of dichlorodifluoromethane and trichlorofluoromethane 
 in disinfection sprays for use in human skin 
 as propellant and solvent and in the form of external agents 
 Cold application in the event of muscle pain and perennials, including 
 Addition of Latschenkiefernöl, Campher, Menthol and Arnikaauszüge 
 or propane and butane, as ready-to-use product 
Mixtures of ethanol aether, camphor spiritus, 
 Soap spiritus and aqueous ammonia solution or 
 of some of these liquids for animals 
Molk concentrate with the addition of substances of non-active substance 
 or preparations 
Myrrhal tincture 
Sodium chloride ad us.  vet. 
sodium hydrogen carbonate, 
 as tablets, granules or in capsules also with addition 
 Substances or preparations which are not active in medicinal products 
 Medicinal products for manufacture 
Sodium monohydrogen phosphate 
Sodium sulphate decahydrate (Glauber salt) 
Nelkenöl, etheric 
Nelkentintincture with ethanol 70% in ratio 1: 5 
Opodeldok, liquid 
Pappelsalbe 
Pepsinwine as a ready-to-use product 
Peppermint oil, ethereal 
 in an average daily dose of up to 12 drops, or as a capsule, including 
 Addition of substances or preparations which are not active in medicinal products, as 
 Finished pharmaceuticals, each up to a single dose of 0.2 ml per capsule 
 or  a maximum daily dose of 0.6 ml 
Peppermint syrup as a ready-to-use medicine 
Peppermint spiritus, made of peppermint oil with ethanol 90% 
 in a ratio of 1: 10 
Peppermint water 
Pomeranic Blossom Oil, essential 
Pomeranzendish oil, ethereal 
Pomeranza syrup as a ready-to-use medicine 
Pyrethrum extract for use in animals with 
 Addition of substances which are not active in medicinal products or 
 Preparations as ready-to-use products 
Ratanhiatinktur 
Riechsalt 
castor oil, 
 also refined, also in capsules 
Rosenhonig 
Rosmarinleaves 
 and their preparations, even with the addition of medicinal products 
 Active substances or preparations as ready-to-use products 
Rosmarin oil, essential 
Rosmarinspiritus 
Antiskid trihydrate in pre-prepared medicinal products up to a maximum daily dose 
 of 100 mg 
Salinoil, essential 
Saline water 
Salicyltalg 
Oxygen for medical purposes-also for use in the 
Appendix 3-diseases and diseases- 
Sulphur 
Sulphur, finely divided (sulphur-blooded), for external use 
Seifenspiritus 
Silver nitrate solution, aqueous 1%, in ampoules in 
 Weekly bed packs 
silica (silica), 
 as a Streupulver, even with the addition of medicinal products 
 more effective substances or preparations than 
 Medicinal products for manufacture 
Top-of-the-line extract as a finished product 
Spitzwegerichsirup as a ready-to-use medicine 
Talc 
Tamponadestmature, impregnated with white vaseline 
Tannin-protein tablets as ready-to-use medicinal products 
Thyme oil, etheric 
Thymol for use in bees 
Clay, whiter 
Troxerutin up to a maximum daily dose of 300 mg 
Vaselin, white or yellow 
Vaselin oil, white or yellow, for external use, as 
 Medicinal products for manufacture 
Juniper extract 
Juniperm as a ready-to-use product 
Juniper syrup as a ready-to-use medicine 
Juniper spiritus 
Watte impregnated with capsicumextrakt 
Watte impregnated with iron (III) chloride 
tartaric acid 
White thorn blossoms and preparations, white thorn leaves and preparations, 
White cod fruits and preparations 
Wheat germ in capsules as a ready-to-use medicine 
 as pearls also with the addition of substances which are not active in medicine 
 or preparations as ready-to-use products 
cinnamon oil, ethereal 
Cinnamon syrup as ready-to-use medicine 
Zinc oxide with the addition of medicinal products not more effective 
 Substances or preparations as powders, whether or not containing 
 of liver tran, as a ready-to-use product 
zinc ointment, 
 Also with the addition of liver tran, as a ready-to-use product 
Lemon oil, essential   

Unofficial table of contents

Annex 1b (to § 1 para. 1 no. 2, § 7 para. 1 no. 2 and § 8 para. 1 no. 2)

(Fundstelle des Originaltextes: BGBl. I 1988, 2156-2157;
with regard to of the individual amendments. Footnote)

Adonish-Roman	Adonis vernalis
Aloe species
Alraune	Mandragora officinarum
Aristolochia species
Bärlappkraut
Legwell -with the exception of preparations for external use which do not contain more than 100 myg of pyrrolizidine alkaloids with a 1,2-unsaturated Necingerüst, including their N-oxides, in the daily dose,
Besenginster	Cytisus scoparius
Blasentang	Fucus vesiculosus
Cascararinde (Sagradarinde)	Rhamnus purshiana
Digitalis species
Iron hat	Aconitum napellus
Ephedra	Ephedra distachya
Ephedra species
Farnkraut species
Faultree bark	Rhamnus frangula
Fleckenschierling	Conium maculatum
Foot-leaf species	Podophyllum peltatum
	Podophyllum hexandrum
Garden Leaf Leaves	Ruta graveolens
Gelsemium (Yellow Jasmine)	Gelsemium sempervirens
Giftlattich	Lactuca virosa
Giftsumach	Toxicodendron quercifolium
Goldregen	Laburnum anagyroides
Herbsttimeless	Colchicum autumnale
Huflattich -except preparations of horseshoe leaves for internal use which are not more than 1 myg in the daily dose as fresh plant juice or extract, and not more than 10 myg of pyrrolizidine alkaloids with 1,2-unsaturated Necingerüst including their N-oxides,
Hydrastis (Canadians yellow)	Hydrastis canadensis
Hyoscyamus species
Ignatius bean	Strychnos ignatii
Evergreen-Species (Vinca)
Ipecacuanha (crusher)	Cephaelis ipecacuanha
	Cephaelis acuminata
Jakobskraut	Senecio jacobaea
Jalape	Ipomoea purga
Johanniskraut and his
Preparations -except in a daily dose of up to 1 g of drug equivalent and up to 1 mg of hyperforin, and as tea, fresh plant juice or oily preparations for external use,
Cascarillo Room (Granatill)	Croton cascarilla
	Croton eluteria
Koloquinte	Citrullus colocynthis
Crossthorn berries and its
Preparations
Krotonölbaum (Granatill)	Croton tiglium
Kitchen clamp	Pulsatilla pratensis
	Pulsatilla vulgaris
Life Tree	Thuja occidentalis
Lobelien species
Maigolk	Convallaria majalis
Sea onion, white and red	Urginea maritima
Parent grain	Secale cornutum
Night shadow, bittersweet	Solanum dulcamara
Nieswurz, green	Helleborus viridis
Nieswurz, black (Christrose)	Helleborus niger
Oleander	Nerium oleander
Pestwurz -except preparations of pestwurzwurzelstock for internal use, which in the daily dose contain no more than 1 myg pyrrolizidine alkaloids with 1,2-unsaturated Necingerüst including their N-oxides-
Physostigma species
Pilocarpus species
Rainfarn	Chrysanthemum vulgare
Rauwolfia	Rauwolfia serpentina
	Rauwolfia tetraphylla
	Rauwolfia vomitoria
Rhabarber	Rheum palmatum
	Rheum officinale
Sadebaum	Juniperus sabina
Scammonia	Convolvulus scammonia
Opium poppy	Papaver somniferum
Schöllkraut	Chelidonium majus
Senna	Cassia angustifolia
	Cassia senna
Puncture Species (Datura)
Stephansrittersporn	Delphinium staphisagria
Stropanthus species
Strychnos species
Tollkirsche	Atropa bella-donna
Tollkraut species (Scopolia)
Water Schierling	Cicuta virosa
Yohimbebaum	Pausinystalia yohimba

Unofficial table of contents

Appendix 1c (to § 1 para. 1 no. 3)

Source of the original text: BGBl. I 1988, 2158-2159;
with regard to of the individual amendments. Footnote

Alantwurzelstock	Helenii rhizoma
Anis	Anisi fructus
Arnikablüten and -root	Arnicae flos et radix
Bärentraubenblätter	Uvae ursi folium
Baldrian root	Valerianae radix
Bibernellroot	Pimpinellae radix
Birch leaves	Betulae folium
Bitterkleeblätter	Trifolii fibrini folium
Bean sleeves	Phaseoli pericarpium
Fire-scarves	Urticae herba
Breakage	Herniariae herba
Condurangorinde	Condurango cortex
Eibischwurzel	Althaeae radix
Enzianwurzel	Gentianae radix
Dybergine	Genistae tinctoriae herba
Fennel	Foeniculi fructus
Goose fingerkraut	Anserinae herba
Goldrud	Solidaginis herba
Hagebutten	Cynosbati fructus cum semine
Hamamelis leaves	Hamamelidis folium
Skin root	Ononidis radix
Herdsman's herb herb	Bursae pastoris herba
Elderflower	Sambuci flos
Hops and spigs	Lupuli glandula et strobulus
Horseshoe leaves	Farfarae folium
In preparations for internal use, which contain in the daily dose no more than 1 my pyrrolizidine alkaloids with 1,2-unsaturated Necingerüst, including their N-oxides
Ingwerwurzelstock	Zingiberis rhizoma
Icelandic Moos	Lichen islandicus
Johanniskraut	Hyperici herba
Kalmuswurzelstock	Calami rhizoma
Chamomile flowers	Matricariae flos
Garlic onion	Allii sativi bulbus
Koriander Fruit	Coriandri fructus
Crossthorn berries	Rhamni cathartici fructus
Cumin	Carvi fructus
Liebstöckelwurzel	Levistici radix
Lion-tooth-whole plant	Taraxaci radix cum herba
Lung wort	Pulmonariae herba
Majorankraut	Majoranae herba
Mariendistelkraut	Cardui mariae herba
Masterwort rootworm	Imperatoriae rhizoma
Melissa sheets	Melissae folium
Mistelkraut	Visci herba
Orthosiphon	Orthosiphonis folium
Passionflower Wort	Passiflorae herba
Parsley fruits	Petroselini fructus
Parsley Herb	Petroselini herba
Parsley root	Petroselini radix
Peppermint Leaves	Menthae piperitae folium
Pomeranza Sheets	Aurantii folium
Pomeranza Blossoms	Aurantii flos
Pomeranzenshells	Aurantii pericarpium
Queckenwurzelstock	Graminis rhizoma
Rettich	Raphani radix
Rosmarinleaves	Rosmarinus officinalis
Sage leaves	Salviae folium
Horsetail mkraut	Equiseti herba
Sheep garbenkraut	Millefolii herba
Schlehdornblüten	Pruni spinosae flos
Soap root, red	Saponariae radix rubra
Sunflower root	Echinaceae angustifoliae radix
Suntan	Droserae herba
Spitzwegerichkraut	Plantaginis lanceolatae herba
Steinkleekraut	Meliloti herba
Liquorice root	Liquiritiae radix
Thousand-year-old	Centaurii herba
Thyme	Thymi herba
Bird knukraut	Polygoni avicularis herba
Juniper berries	Juniperi fructus
Juniper wood	Juniperi lignum
Walnut Leaves	Juglandis folium
Wegwartenwurzel (Zichorienwurzel)	Cichorii radix
Weidenrinde	Salicis cortex
White Thorn Leaves	Crataegi folium
White thorn blossoms	Crataegi flores
White thorns	Crataegi fructus
Wermutkraut	Absinthii herba
Ysopkraut	Hyssopi herba
Citterwurzelstock	Zedoariae rhizoma

Unofficial table of contents

Appendix 1d (to § 1 para. 2 nos. 1 and 2)

Source of the original text: BGBl. I 1988, 2160;
with regard to of the individual amendments. Footnote

Birch leaves	Betulae folium
Baldrian root	Valerianae radix
Eibischwurzel	Althaeae radix
Fennel	Foeniculi fructus
Hagebutten	Cynosbati fructus cum semine
Elderflower	Sambuci flos
Hop cones	Lupuli strobulus
Horseshoe leaves	Farfarae folium
In preparations for internal use, which contain no more than 10 myg of pyrrolizidine alkaloids with 1,2-unsaturated Necingerüst, including their N-oxides, in the daily dose
Icelandic Moos	Lichen islandicus
Chamomile flowers	Matricariae flos
Linden blossoms	Tiliae flos
Mateblätter	Mate folium
Melissa sheets	Melissae folium
Orthosiphon	Orthosiphonis folium
Peppermint Leaves	Menthae piperitae folium
Sage leaves	Salviae folium
Horsetail mkraut	Equiseti herba
Sheep garbenkraut	Millefolii herba
Spitzwegerichkraut	Plantaginis lanceolatae herba
Thousand-year-old	Centaurii herba
White Thorn Leaves	Crataegi folium
White thorn blossoms	Crataegi flores
White thorns	Crataegi fructus

Unofficial table of contents

Annex 1e (to § 1 para. 2 no. 2)

Source of the original text: BGBl. I 1988, 2160-2161;
with regard to of the individual amendments. Footnote

Angelikawurzel	Angelicae radix
Anis	Anisi fructus
Bibernellroot	Pimpinellae radix
Fire-scarves	Urticae herba
Breakage	Herniariae herba
Brunnenkressenkraut	Nasturtii herba
Condurangorinde	Condurango cortex
Curcumawurzelstock (yellowland roots)	Curcumae longae rhizoma
Enzianwurzel	Gentianae radix
Eucalyptus leaves	Eucalypti folium
Goose fingerkraut	Anserinae herba
Goldrud	Solidaginis herba
Hamamelisrinde	Hamamelidis cortex
Skin root	Ononidis radix
Heidekraut	Callunae herba
Heart-spannkraut	Leonuri cardiacae herba
Javanese yellowish	Curcumae xanthorrhizae rhizoma
Kalmuswurzelstock	Calami rhizoma
Koriander Fruit	Coriandri fructus
Cumin	Carvi fructus
Liebstöckelwurzel	Levistici radix
Lion-tooth-whole plant	Taraxaci radix cum herba
Malvenous Leaves	Malvae folium
Mariendistelkraut	Cardui Mariae herba
Paprika (Spanish pepper fruits)	Capsici fructus
Primelwurzel	Primulae radix
Queckenwurzelstock	Graminis rhizoma
Quendelkraut	Serpylli herba
Sunflower root	Echinaceae angustifoliae radix
Liquorice root	Liquiritiae radix
Thyme	Thymi herba
Tormentillerzelstock	Tormentillae rhizoma
Juniper berries	Juniperi fructus
Weidenrinde	Salicis cortex
Wermutkraut	Absinthii herba

Unofficial table of contents

Annex 2a (to § 2 para. 1 no. 1)

Source of the original text: BGBl. I 1988, 2161;
with regard to of the individual amendments. Footnote

Essential oils, to the extent that they are mentioned in Appendix 1a

Ammonium chloride

Anethol Ascorbic Acid up to a single dose of 20 mg and its calcium, potassium and sodium salts

Benzyl alcohol

Campher

Cetylpyridinium chloride

Cineol (Eucalyptol)

Citronic acid

alpha-dodecyl-omega-hydroxypoly (oxyethylene) (oxypolyethoxydodecan) up to a single dose of 5 mg

Extracts of plants and parts of plants, including mixtures thereof, insofar as they are not obtained from the plants or parts thereof referred to in Appendix 1b

Fennel honey

Menglytate (ethyl glycollic acid menthyl ester)

Menthol

Rosenhonig

Salts of natural mineral, saline and seawater and the artificial salts thereof

Liquorice juice

Thymol

Toluene balm

tartaric acid

Unofficial table of contents

Appendix 2b (to § 2 para. 1 no. 2)

Source of the original text: BGBl. I 1988, 2161

Agar

Figs and their preparations

Fennel

Cumin

Lactose

Linseed and its preparations

Manna

Paraffin, thick and thin liquid, up to a content of 10% in non-liquid preparations

Plums and their preparations

Castor oil, also refined

Tamarind fruits and their preparations

Tragant

Wheat bran

Unofficial table of contents

Annex 2c (to § 2 para. 1 no. 3)

2-aminoethanol

Benzalkonium chloride

Benzocaine

Benzyl benzoate

2,4-dihydroxybenzoic acid

2,6-dihydroxybenzoic acid

3,5-dihydroxybenzoic acid

alpha-dodecyl-omega-hydroxypoly (oxyethylene)

Acetic acid

Larch terpentin

Menthol

Lactic acid up to 10%

Salicylic acid up to 40%

Unofficial table of contents

Appendix 3 (to § § 6, 7 para. 1 no. 4, para. 2 no. 1 and § 8 para. 1 no. 4)

(Fundstelle: BGBl. I 1988, 2162;
with regard to of the individual amendments. (footnote) A. Diseases and suffering in humans

1.

In the Infection Protection Act of 20 July 2000 (BGBl. I p. 1045), diseases caused by pathogens

2.

Swasal diseases

3.

Diseases of metabolism and internal secretion, with the exception of vitamin and mineral deficiency and alimentary obesity

4.

Blood and blood-forming organs, other than iron deficiency anaemia

5.

Organic diseases

a)

of the nervous system

b)

of the eyes and ears, with the exception of blenorrhoea prophylaxis

c)

of the heart and of the vessels, excluding general arteriosclerosis and frost bulls

d)

the liver and the pancreas

e)

of the Harn and Gender organs

6.

Ulcers of the stomach and the intestines

7.

Epilepsy

8.

Mental illness, psychosis, neuroses

9.

trunked

10.

Complications of pregnancy, chili-ment and weekly bed

11.

Diseases of the pulmonary parenchyma

12.

Wormdiseases

13.

Pathological changes in blood pressure

14.

Dietary diseases of the infant

15.

Eczema, psoriasis, infectious skin diseases

B. Diseases and suffering in animals

1.

Communicable diseases of the animals, except for ectoparasitic and dermatomycotic diseases not subject to notifiable animal health requirements

2.

Euteric diseases in cows, goats and sheep, except for the prevention of the transmission of udder diseases by medicinal products intended for external use and whose effect is not based on the absorption of the active ingredients

3.

Colic in horses and cattle

4.

Metabolic diseases and diseases of the internal secretion organs, with the exception of vitamin and mineral deficiency

5.

Diseases of the blood and of the blood-forming organs

6.

Swasal diseases

7.

Fertility disorders in horses, cattle, swine, sheep and goats

Unofficial table of contents

Appendix 4 (to § 7 para. 1 no. 1 and § 8 para. 1 no. 1)

(Fundstelle: BGBl. I 1988, 2163;
with regard to of the individual amendments. Footnote)

alpha-(aminomethyl) benzyl alcohol (phenylaminoethane),
	whose derivatives and salts
p-aminophenol, its derivatives and their derivatives
	Salts
2-Amino-1-phenylpropanol (phenylaminopropanol),
	whose derivatives and salts
Anthraquinone, its derivatives and their salts
Antimony compounds
Bisacodyl
Lead Connections
boric acid and its salts, except for buffering and/or
	Isotonization in wetting solutions or disinfection solutions for contact lenses
Brominated compounds, other than inverted-soaps,
	In addition, in medicinal products intended for the detection of the condition, condition or functions of the body or of mental conditions and of disinfectants intended solely for external use, mouth and mouth, RachendesinfectionsMeans
Carbamic acid derivatives
Carbamic acid esters and amides with insecticides,
	acaricidal or fungicidal effect, except in pre-filled medicinal products for external use in dogs and cats
Quinine and its salts, other than quinine trimercury (II) dioxide-sulphate
	In preparations up to 2.75% for the prevention of sexually transmitted diseases, as a ready-to-use product
Progeny derivatives, except in preparations for external
	Use, mouth and throat disinfection as well as in preparations up to 3% for contraception as ready-to-use medicinal products; the exception does not apply to halogenated hydroxyquinolines
Chlorinated hydrocarbons
6-chlorthymol, except for external use
Dantron
2-Dimethylaminoethyl-benzilate (benzilate-2-dimethyl-amino-ethyl ester)
fluorides, soluble, other than in preparations,
	if a daily dose corresponding to a fluorine content of up to 2 mg is indicated on containers and outer envelopes
Formaldehyde
Gold Connections
Medicinal buttleber oil, other than for use in humans
	in preparations with a daily dose of not more than 6 000 IU of vitamin A and 400 IU of vitamin D and other than for use in animals in preparations with a daily dose of not more than 4 000 IU of vitamin A and 250 IU of vitamin D
Healing waters, bottled in bottles, per litre
	a) 0.04 mg of arsenic corresponding to 0.075 mg of hydrogenarsenate or more, or b) more than 3,7 Becquerel 226 Radium or more than 100 Becquerel 222 Radon included
Heart-active glycosides
Iodine, other than in preparations not containing
	more than 5% iodine and in medicinal products according to § 44 (2) (1a) and (b) of the Medicines Act
Iodine compounds, except in medicinal products intended for this purpose.
	, the condition, condition or functions of the body or mental state shall be detected, disinfectants intended exclusively for external use and in medicinal products according to § 44 (2) (1a) and (b) of the Pharmaceutical legislation, also in preparations for the manufacture of baths and soaps, also using iodine, for external use, as ready-to-use medicinal product
Sodium picosulfate
Oxazine and its hydrogenation products,
	their salts, their derivatives and their salts
Paraffin, thick and thin liquid, with the exception of the outer
	Use or up to a content of 10% in non-liquid preparations
paraformaldehyde
Pentetrazole
Phenethylamine, its derivatives and salts
Phenolphthalein
phosphoric acid, polyphosphoric acid, substituted
	Phosphoric acid (e. g. thiophosphoric acid) esters and amides, including esters with nitrophenol and methylhydroxycoumarin with insecticide, acaricidal or fungicidal action, with the exception of ready-to-use medicinal products for external use in dogs or Cats
Procaine and its salts for oral use
pyrazole and its hydrogenation products, its salts,
	their derivatives and their salts
Resorcinol
Salicylic acid, its derivatives and their salts, excluding
	Preparations for external use, as well as salicylic acid esters in disinfectants, mouth and throat disinfectants, which are intended exclusively or predominantly for external use
Mustard oils
Vitamin A, other than preparations with a daily dose of
	not more than 5000 IU and a single dose of no more than 3 000 IU, also with the addition of vitamin D with a daily dose of not more than 400 IU, as a medicinal product for human use, and with the exception of preparations with a daily dose of not more than 4 000 IU, also with the addition of vitamin D with a daily dose of not more than 250 IU, as a medicinal product for animals
Vitamin D, other than preparations with a daily dose of
	not more than 400 IU as a medicinal product for human use, and other than preparations with a daily dose of not more than 250 IU as a medicinal product for animals